| molecular function |
|---|
| | GO:0048365 | | Rac GTPase binding | | Interacting selectively and non-covalently with Rac protein, any member of the Rac subfamily of the Ras superfamily of monomeric GTPases. |
| | GO:0016209 | | antioxidant activity | | Inhibition of the reactions brought about by dioxygen (O2) or peroxides. Usually the antioxidant is effective because it can itself be more easily oxidized than the substance protected. The term is often applied to components that can trap free radicals, thereby breaking the chain reaction that normally leads to extensive biological damage. |
| | GO:0051087 | | chaperone binding | | Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport. |
| | GO:0005507 | | copper ion binding | | Interacting selectively and non-covalently with copper (Cu) ions. |
| | GO:0019899 | | enzyme binding | | Interacting selectively and non-covalently with any enzyme. |
| | GO:0042802 | | identical protein binding | | Interacting selectively and non-covalently with an identical protein or proteins. |
| | GO:0046872 | | metal ion binding | | Interacting selectively and non-covalently with any metal ion. |
| | GO:0016491 | | oxidoreductase activity | | Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0042803 | | protein homodimerization activity | | Interacting selectively and non-covalently with an identical protein to form a homodimer. |
| | GO:0030346 | | protein phosphatase 2B binding | | Interacting selectively and non-covalently with the enzyme protein phosphatase 2B. |
| | GO:0004784 | | superoxide dismutase activity | | Catalysis of the reaction: 2 superoxide + 2 H+ = O2 + hydrogen peroxide. |
| | GO:0008270 | | zinc ion binding | | Interacting selectively and non-covalently with zinc (Zn) ions. |
| biological process |
|---|
| | GO:0000187 | | activation of MAPK activity | | The initiation of the activity of the inactive enzyme MAP kinase (MAPK). |
| | GO:0007568 | | aging | | A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
| | GO:0008089 | | anterograde axonal transport | | The directed movement of organelles or molecules along microtubules from the cell body toward the cell periphery in nerve cell axons. |
| | GO:0060088 | | auditory receptor cell stereocilium organization | | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a stereocilium. A stereocilium is an actin-based protrusion from the apical surface of auditory hair cells. |
| | GO:0007569 | | cell aging | | An aging process that has as participant a cell after a cell has stopped dividing. Cell aging may occur when a cell has temporarily stopped dividing through cell cycle arrest (GO:0007050) or when a cell has permanently stopped dividing, in which case it is undergoing cellular senescence (GO:0090398). May precede cell death (GO:0008219) and succeed cell maturation (GO:0048469). |
| | GO:0006879 | | cellular iron ion homeostasis | | Any process involved in the maintenance of an internal steady state of iron ions at the level of a cell. |
| | GO:0071318 | | cellular response to ATP | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ATP (adenosine 5'-triphosphate) stimulus. |
| | GO:0071276 | | cellular response to cadmium ion | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus. |
| | GO:0034599 | | cellular response to oxidative stress | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals. |
| | GO:0035865 | | cellular response to potassium ion | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a potassium ion stimulus. |
| | GO:0007566 | | embryo implantation | | Attachment of the blastocyst to the uterine lining. |
| | GO:0006749 | | glutathione metabolic process | | The chemical reactions and pathways involving glutathione, the tripeptide glutamylcysteinylglycine, which acts as a coenzyme for some enzymes and as an antioxidant in the protection of sulfhydryl groups in enzymes and other proteins; it has a specific role in the reduction of hydrogen peroxide (H2O2) and oxidized ascorbate, and it participates in the gamma-glutamyl cycle. |
| | GO:0060047 | | heart contraction | | The multicellular organismal process in which the heart decreases in volume in a characteristic way to propel blood through the body. |
| | GO:0050665 | | hydrogen peroxide biosynthetic process | | The chemical reactions and pathways resulting in the formation of hydrogen peroxide (H2O2), a potentially harmful byproduct of aerobic cellular respiration which can cause damage to DNA. |
| | GO:0007626 | | locomotory behavior | | The specific movement from place to place of an organism in response to external or internal stimuli. Locomotion of a whole organism in a manner dependent upon some combination of that organism's internal state and external conditions. |
| | GO:0046716 | | muscle cell cellular homeostasis | | The cellular homeostatic process that preserves a muscle cell in a stable functional or structural state. |
| | GO:0002262 | | myeloid cell homeostasis | | The process of regulating the proliferation and elimination of myeloid cells such that the total number of myeloid cells within a whole or part of an organism is stable over time in the absence of an outside stimulus. |
| | GO:0043066 | | negative regulation of apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| | GO:0045541 | | negative regulation of cholesterol biosynthetic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cholesterol. |
| | GO:0043524 | | negative regulation of neuron apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons. |
| | GO:0060052 | | neurofilament cytoskeleton organization | | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising neurofilaments and their associated proteins. |
| | GO:0001541 | | ovarian follicle development | | The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure. |
| | GO:0055114 | | oxidation-reduction process | | A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons. |
| | GO:0032287 | | peripheral nervous system myelin maintenance | | The process in which the structure and material content of mature peripheral nervous system myelin is kept in a functional state. |
| | GO:0001890 | | placenta development | | The process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin. |
| | GO:0002576 | | platelet degranulation | | The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet. |
| | GO:0043065 | | positive regulation of apoptotic process | | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
| | GO:0043085 | | positive regulation of catalytic activity | | Any process that activates or increases the activity of an enzyme. |
| | GO:0001819 | | positive regulation of cytokine production | | Any process that activates or increases the frequency, rate or extent of production of a cytokine. |
| | GO:1902177 | | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | | Any process that activates or increases the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway. |
| | GO:0032930 | | positive regulation of superoxide anion generation | | Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell. |
| | GO:0072593 | | reactive oxygen species metabolic process | | The chemical reactions and pathways involving a reactive oxygen species, any molecules or ions formed by the incomplete one-electron reduction of oxygen. They contribute to the microbicidal activity of phagocytes, regulation of signal transduction and gene expression, and the oxidative damage to biopolymers. |
| | GO:0043087 | | regulation of GTPase activity | | Any process that modulates the rate of GTP hydrolysis by a GTPase. |
| | GO:0033081 | | regulation of T cell differentiation in thymus | | Any process that modulates the frequency, rate or extent of T cell differentiation in the thymus. |
| | GO:0008217 | | regulation of blood pressure | | Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure. |
| | GO:0051881 | | regulation of mitochondrial membrane potential | | Any process that modulates the establishment or extent of the mitochondrial membrane potential, the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane. |
| | GO:0040014 | | regulation of multicellular organism growth | | Any process that modulates the frequency, rate or extent of growth of the body of an organism so that it reaches its usual body size. |
| | GO:0046620 | | regulation of organ growth | | Any process that modulates the frequency, rate or extent of growth of an organ of an organism. |
| | GO:0045859 | | regulation of protein kinase activity | | Any process that modulates the frequency, rate or extent of protein kinase activity. |
| | GO:0060087 | | relaxation of vascular smooth muscle | | A negative regulation of smooth muscle contraction resulting in relaxation of vascular smooth muscle. The relaxation is mediated by a decrease in the phosphorylation state of myosin light chain. This can be achieved by removal of calcium from the cytoplasm to the sarcoplasmic reticulum lumen through the action of Ca2+ ATPases leading to a decrease myosin light chain kinase activity, and through calcium-independent pathways leading to a increase in myosin light chain phosphatase activity. |
| | GO:0019430 | | removal of superoxide radicals | | Any process, acting at the cellular level, involved in removing superoxide radicals (O2-) from a cell or organism, e.g. by conversion to dioxygen (O2) and hydrogen peroxide (H2O2). |
| | GO:0001975 | | response to amphetamine | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amphetamine stimulus. Amphetamines consist of a group of compounds related to alpha-methylphenethylamine. |
| | GO:0046677 | | response to antibiotic | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms. |
| | GO:0097332 | | response to antipsychotic drug | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antipsychotic drug stimulus. Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. |
| | GO:0048678 | | response to axon injury | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an axon injury stimulus. |
| | GO:0034465 | | response to carbon monoxide | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carbon monoxide (CO) stimulus. |
| | GO:0046688 | | response to copper ion | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus. |
| | GO:0042493 | | response to drug | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. |
| | GO:0045471 | | response to ethanol | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. |
| | GO:0009408 | | response to heat | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. |
| | GO:0042542 | | response to hydrogen peroxide | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus. |
| | GO:0031667 | | response to nutrient levels | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients. |
| | GO:0010033 | | response to organic substance | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus. |
| | GO:0006979 | | response to oxidative stress | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals. |
| | GO:0000302 | | response to reactive oxygen species | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals. |
| | GO:0000303 | | response to superoxide | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a superoxide stimulus. Superoxide is the anion, oxygen-, formed by addition of one electron to dioxygen (O2) or any compound containing the superoxide anion. |
| | GO:0001895 | | retina homeostasis | | A tissue homeostatic process involved in the maintenance of an internal equilibrium within the retina of the eye, including control of cellular proliferation and death and control of metabolic function. |
| | GO:0008090 | | retrograde axonal transport | | The directed movement of organelles or molecules along microtubules from the cell periphery toward the cell body in nerve cell axons. |
| | GO:0007605 | | sensory perception of sound | | The series of events required for an organism to receive an auditory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Sonic stimuli are detected in the form of vibrations and are processed to form a sound. |
| | GO:0007283 | | spermatogenesis | | The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis. |
| | GO:0042554 | | superoxide anion generation | | The enzymatic generation of superoxide, the superoxide anion O2- (superoxide free radical), or any compound containing this species, by a cell in response to environmental stress, thereby mediating the activation of various stress-inducible signaling pathways. |
| | GO:0006801 | | superoxide metabolic process | | The chemical reactions and pathways involving superoxide, the superoxide anion O2- (superoxide free radical), or any compound containing this species. |
| | GO:0048538 | | thymus development | | The process whose specific outcome is the progression of the thymus over time, from its formation to the mature structure. The thymus is a symmetric bi-lobed organ involved primarily in the differentiation of immature to mature T cells, with unique vascular, nervous, epithelial, and lymphoid cell components. |
| | GO:0019226 | | transmission of nerve impulse | | The neurological system process in which a signal is transmitted through the nervous system by a combination of action potential propagation and synaptic transmission. |
| cellular component |
|---|
| | GO:1904115 | | axon cytoplasm | | Any cytoplasm that is part of a axon. |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0031410 | | cytoplasmic vesicle | | A vesicle found in the cytoplasm of a cell. |
| | GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| | GO:0032839 | | dendrite cytoplasm | | All of the contents of a dendrite, excluding the surrounding plasma membrane. |
| | GO:0031045 | | dense core granule | | Electron-dense organelle with a granular internal matrix; contains proteins destined to be secreted. |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0031012 | | extracellular matrix | | A structure lying external to one or more cells, which provides structural support for cells or tissues. |
| | GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| | GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| | GO:0005764 | | lysosome | | A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions. |
| | GO:0005758 | | mitochondrial intermembrane space | | The region between the inner and outer lipid bilayers of the mitochondrial envelope. |
| | GO:0005759 | | mitochondrial matrix | | The gel-like material, with considerable fine structure, that lies in the matrix space, or lumen, of a mitochondrion. It contains the enzymes of the tricarboxylic acid cycle and, in some organisms, the enzymes concerned with fatty acid oxidation. |
| | GO:0005739 | | mitochondrion | | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
| | GO:0043209 | | myelin sheath | | An electrically insulating fatty layer that surrounds the axons of many neurons. It is an outgrowth of glial cells: Schwann cells supply the myelin for peripheral neurons while oligodendrocytes supply it to those of the central nervous system. |
| | GO:0043005 | | neuron projection | | A prolongation or process extending from a nerve cell, e.g. an axon or dendrite. |
| | GO:0043025 | | neuronal cell body | | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
| | GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| | GO:0005777 | | peroxisome | | A small organelle enclosed by a single membrane, and found in most eukaryotic cells. Contains peroxidases and other enzymes involved in a variety of metabolic processes including free radical detoxification, lipid catabolism and biosynthesis, and hydrogen peroxide metabolism. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| | GO:0043234 | | protein complex | | A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical. |
| | GO:0030141 | | secretory granule | | A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules. |
Description
